Once Daily Pharma

The gallery of digital pharma marketing screenshots.

  • Browse by Drug Type
    • Prescription Drugs
    • Boxed Warning Drugs
  • Browse by Tactic
    • Pharma Banner Ads
    • Pharma on Social Media
    • Pharma Email Programs
    • Pharma Paid Search Ads
    • Pharma Website Features
    • Now Approved Websites
    • Now Available Websites
    • Launch Websites
  • Browse by Brand
  • Outside-the-Box
  • Unbranded Campaigns
  • Subscribe for Updates

Coming Soon

Rebinyn Email Program

Apr 10, 2018Apr 11, 2018
Rebinyn Available in 2018 Email from Novo Nordisk to HCPs

Email 1, subject line 1: A new treatment option for your patients Sent on: Nov 11, 2017 at 10am EST Same email, resent: Email 1, subject line 2: FDA Approved for 2018: Rebinyn® (Coagulation Factor IX [Recombinant], GlycoPEGylated) Sent On: Jan 21, 2018 at 4pm EST   Email 2 subject line: Now available: Rebinyn® (Coagulation Factor IX [Recombinant], GlycoPEGylated) Continue reading

Continue reading

Emails Coming Soon

Endari: Coming Soon Page

Aug 29, 2017Aug 30, 2017
Endari Coming Soon Page

Continue reading

Websites Coming Soon

Subscribe for Updates

Get the latest updates in digital pharma marketing. Subscribe to our weekly emails:
  • This field is for validation purposes and should be left unchanged.

Search by Keyword

Browse by Tactic

  • Banner Ads (85)
  • Collection of Live Links (3)
  • Emails (31)
  • Outside-the-box Pharma (25)
  • Paid Search (21)
  • Social Media (32)
    • Paid Social (24)
  • Trends (2)
  • Unbranded (54)
  • Uncategorized (1)
  • Website Features (55)
    • Content (8)
    • Interactive (13)
  • Websites (150)
    • Launch (53)
    • Now Approved (62)
    • Now Available (15)
    • PI-Only Launch (3)
Guide to digital pharma banner ads: regulations, OPDP, and best practices
  • Browse by Drug Type
  • Browse by Brand
  • Subscribe
  • Suggest an Example
  • Healthcare Marketing Agencies
  • Follow @OnceDailyPharma
  • Contact Us

Trademarks featured on this site are the property of their respective owners.
Materials provided under the Fair Use doctrine of the US Copyright Law.

© OnceDailyPharma. All rights reserved.
Theme credit: Unite
Join 1000+ of top pharma marketers and get the latest updates in your inbox
  • This field is for validation purposes and should be left unchanged.

We’ll never share or sell your personal info. Ever.